open access to scientific and medical research

Back to Journals » Stem Cells and Cloning: Advances and Applications » Volume 7

Review

Noteworthy Comment: A review of treatments for meyelodysplastic syndrome patients who are usually older than 60. The treatments include allogenic stem cell transplantation in combination with reduced-intensity conditioning and hypomethylating agents .

Highly-accessed

Some aspects of allogeneic stem cell transplantation in patients with myelodysplastic syndrome: advances and controversy

Total article views		HTML views	PDF downloads	Totals
8,905	Dovepress*	8,150+	1,661	9,811
	PubMed Central*	755	308	1,063
	Totals	8,905	1,969	10,874
*Since 4 December 2014 +Since July 2016

View citations on PubMed Central and Google Scholar